Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ORCL vs MRNA✓SelectedUSD · MRNAORCL vs MRNA performance historyLatest closeAs of-2.92%11/19
Stock and ETF performance explorer

ORCL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+25.0%
MRNA return
-25.6%
Excess return
+50.7%
Maximum drawdown
-65.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.9%+1.3%-4.2%-3.0%
7D-13.0%-13.8%+0.8%-12.3%
30D-15.7%-17.7%+2.0%-14.9%
3M-22.8%+14.3%-37.1%-23.7%
6M-38.6%+336.0%-374.6%-47.0%
YTD-42.5%+575.9%-618.4%-53.2%
1Y-50.3%+724.4%-774.7%-60.6%
3Y-0.7%+160.8%-161.5%-15.3%
All+25.0%-25.6%+50.7%+9.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling